Does cognitive dysfunction correlate with neurofilament light polypeptide levels in the CSF of patients with multiple sclerosis?

OBJECTIVE: To investigate whether neurofilament light polypeptide (NfL) level in cerebrospinal fluid (CSF), currently a prognostic biomarker of neurodegeneration in patients with multiple sclerosis (MS), may be a potential biomarker of cognitive dysfunction in MS. METHODS: This observational case–co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalatha, Thaleia, Arnaoutoglou, Marianthi, Koukoulidis, Theodoros, Hatzifilippou, Eleni, Bouras, Emmanouil, Baloyannis, Stavros, Koutsouraki, Effrosyni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567748/
https://www.ncbi.nlm.nih.gov/pubmed/30982375
http://dx.doi.org/10.1177/0300060519840550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567748/
https://www.ncbi.nlm.nih.gov/pubmed/30982375
http://dx.doi.org/10.1177/0300060519840550

Ejemplares similares